The document describes research that engineered the 1-deoxy-D-xylulose 5-phosphate (DXP) pathway in the yeast Saccharomyces cerevisiae. Key findings include:
- An engineered strain was able to grow in the absence of mevalonate, reaching 80% of growth compared to strains with mevalonate added.
- The DXP pathway became functional enough to support moderate growth without the mevalonate pathway, but growth on agar without mevalonate was not achieved.
- This work established a foundation for further optimizing yeast to produce bioenergy-relevant isoprenoids through the DXP pathway under industrial conditions.